SSA
TARO

Schonfeld Strategic Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,992
Closed -$459K – 2500
2023
Q4 		$459K Buy
10,992
+4,492
+69% +$166K ﹤0.01% 1314
2023
Q3 		$245K Buy
+6,500
New +$244K ﹤0.01% 1367

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Schonfeld Strategic Advisors's TARO Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 10,992 shares — an estimated $459K sold.

Schonfeld Strategic Advisors first reported a position in TARO in Q3 2023 and held it in 2 quarters. The position peaked at $459K in Q4 2023. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,992 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $459K.
  • Schonfeld Strategic Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2023 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $459K in Q4 2023.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.